Philip Morris Health Shift: Vectura Sale for $198 Million

Tuesday, 17 September 2024, 06:21

Health is at the forefront as Philip Morris plans to sell Vectura for $198 million after facing criticism over its healthcare shift. This sale marks a pivotal moment for PMI, which previously acquired Vectura in its quest to transform into a broader healthcare entity. Critics argue that PMI's restructuring efforts have not met expectations, hence prompting this decision.
LivaRava_Health_Default_2.png
Philip Morris Health Shift: Vectura Sale for $198 Million

Health Shift and Sale Details

In a strategic move reflecting its challenging transformation journey, Philip Morris International (PMI) decided to sell Vectura for $198 million. The Marlboro maker initially acquired Vectura in September 2021...

Criticism and Future Plans

This health shift has faced significant scrutiny from health advocates who question the integrity of PMI’s motives. As PMI attempts to redefine itself within the services of healthcare and wellness...


Disclaimer: The information provided on this site is for informational purposes only and is not intended as medical advice. We are not responsible for any actions taken based on the content of this site. Always consult a qualified healthcare provider for medical advice, diagnosis, and treatment. We source our news from reputable sources and provide links to the original articles. We do not endorse or assume responsibility for the accuracy of the information contained in external sources.

This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.


Related posts


Newsletter

Subscribe to our newsletter for the latest and most reliable health updates. Stay informed and enhance your wellness knowledge effortlessly.

Subscribe